Close Menu

NEW YORK (GenomeWeb) – Scottish startup Natantis said today that it has been awarded £574,000 ($724,497) by the Scottish Enterprise's High Growth Spin-Out Program  to commercialize a device for the automated extraction of cell-free DNA (cfDNA) from blood.

Natantis — founded by researchers at Heriot-Watt University — has developed the CNAsafe device, which it says can extract cfDNA from whole blood in 45 minutes for use in liquid biopsy assays.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.

Aug
29
Sponsored by
PerkinElmer

This webinar will outline how RUCDR Infinite Biologics, the world's largest university-based biorepository, has implemented workflows and processes to support precision medicine applications.

Oct
23
Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.